Research on Influenza A Virus Subtype H1N1 Detailed by a Researcher at University of Nebraska-Lincoln (Lipid nanoparticle-encapsulated DNA vaccine confers protection against swine and human-origin H1N1 influenza viruses).

A recent study conducted at the University of Nebraska-Lincoln has developed a lipid nanoparticle-encapsulated DNA vaccine that shows promise in protecting against both swine and human-origin H1N1 influenza viruses. The vaccine was effective in inducing a robust immune response in pigs and mice, protecting them from infection with the respective viruses. This research is significant as swine influenza A virus is widespread and causes economic losses to the swine industry, and bidirectional transmission between swine and humans is common. The development of this vaccine could help mitigate the impact of the virus on the swine industry and prevent the emergence of reassortant strains. [Extracted from the article]